Qulipta Coupons & Prices

Looking for a Qulipta coupon? Qulipta (atogepant) is a brand-only, once-daily oral tablet taken to prevent migraine, and there is no generic version of it in the United States, so the cash price at the pharmacy counter can be steep. The free Rx.com discount coupon on this page is a cash-price coupon: you can use it whether or not you have insurance, including if you are on Medicare or if a manufacturer savings card is declined. Enter your ZIP code above to see today's price at pharmacies near you, then show the coupon to the pharmacist when you fill your prescription.

What is Qulipta (atogepant) and how does it work?

Qulipta is the US brand name for atogepant (sold as Aquipta in some other markets). It belongs to a class of medicines called calcitonin gene-related peptide (CGRP) receptor antagonists, often called "gepants." CGRP is a protein involved in the pain and inflammation of a migraine attack; atogepant blocks the receptor that CGRP acts on. It is a tablet, not an injection, and it is not a controlled substance.

The FDA first approved Qulipta in September 2021 for the preventive treatment of episodic migraine in adults; the chronic migraine indication was added in April 2023, and the label now covers preventive treatment of migraine in adults. For episodic migraine the dosage is 10 mg, 30 mg, or 60 mg once daily; for chronic migraine it is 60 mg once daily. The key thing to understand is that Qulipta is a daily preventive medicine, taken every day to reduce the number of migraine days you have. It is not a rescue treatment for an attack that has already started, which is the job of an acute medicine such as Ubrelvy or a triptan like sumatriptan. Safety and effectiveness in children have not been established, and use for other headache disorders is not an approved use.

Qulipta cost, coupons, and the manufacturer savings card

Two very different kinds of savings exist for Qulipta, and it helps to know which one applies to you. The manufacturer runs an official savings program for Qulipta (the Qulipta Complete Savings Program), described on the drug's official manufacturer website. Programs like this are generally limited to people with commercial (private) insurance, and eligibility, benefit amounts, and expiration terms vary and change over time, so check the manufacturer's own site for current details. Most manufacturer cards specifically exclude people enrolled in Medicare, Medicaid, TRICARE, or other government coverage. The manufacturer's site is also the place to look for any patient-assistance option for people who cannot afford their medicine.

The Rx.com coupon is a different tool: it is a cash-price discount coupon, not insurance and not a manufacturer card. It is worth using when you have no insurance, when you have Medicare or another government plan that makes you ineligible for the manufacturer card, when Qulipta is not on your plan's formulary, or when your deductible has not been met. You cannot combine it with your insurance benefit on the same fill, but you can compare the two and pay whichever is lower. Prices vary from pharmacy to pharmacy, so it pays to compare before you fill. Enter your ZIP above to see today's price near you and print, text, or show the coupon at the counter.

Is there a generic for Qulipta? Alternatives to compare

No. As of July 2026 there is no FDA-approved generic atogepant marketed in the United States, so "generic Qulipta" is not something a pharmacy can substitute for you. That makes shopping the cash price across pharmacies, and talking with your prescriber about alternatives, the two biggest levers you have.

If cost is the obstacle, these are the categories worth discussing with your doctor. Never switch or stop a preventive medicine on your own.

• Other oral preventives with generics: topiramate is an older migraine preventive that is available as a generic. Prices still vary by pharmacy, so compare before you fill.
• Injectable CGRP preventives (monthly or quarterly): Emgality, Aimovig, and Ajovy are antibody medicines given by self-injection rather than a daily pill. They are brand-only as well, but coverage and manufacturer programs differ.
• Other gepants: Nurtec ODT (rimegepant) is approved both for prevention (taken every other day) and for treating an attack, while Ubrelvy (ubrogepant) is for acute treatment only.
• Rescue medicines: a triptan such as sumatriptan is a separate, as-needed treatment and does not replace a daily preventive.

Qulipta safety, side effects, and interactions

Qulipta does not carry a boxed warning. It is contraindicated in anyone with a history of hypersensitivity to atogepant or any ingredient in the tablet. The label's warnings and precautions include hypersensitivity reactions such as anaphylaxis, trouble breathing, rash, itching, hives, and facial swelling, which can occur days after a dose; new or worsening high blood pressure, which in some reported cases required medication or hospitalization; and Raynaud's phenomenon, meaning new Raynaud's or the return or worsening of an existing case. The label notes that many reported Raynaud's cases had serious outcomes, including hospitalization and disability, generally related to debilitating pain, and that Qulipta should be stopped if signs or symptoms of Raynaud's develop. Get medical help right away for signs of a serious allergic reaction. The most common side effects reported in trials were nausea, constipation, and fatigue or sleepiness; decreased appetite and weight loss have also been reported.

Pregnancy: there are no adequate data on the risk to a developing baby in pregnant women. In animal studies, atogepant caused adverse developmental effects, including decreased fetal and offspring body weight in rats and an increase in fetal structural variations in rabbits, at exposures above those used clinically. Tell your prescriber if you are pregnant or planning to become pregnant; there is a pregnancy exposure registry for people who take Qulipta during pregnancy.

Interactions and special populations. The label sets different dosing rules depending on whether you are treating episodic or chronic migraine, so this is not a one-size-fits-all adjustment:

• Strong CYP3A4 inhibitors: 10 mg once daily, for episodic and chronic migraine alike.
• Strong or moderate CYP3A4 inducers: for episodic migraine, 60 mg once daily, with monitoring for reduced effectiveness; for chronic migraine, Qulipta is not recommended. Weak CYP3A4 inducers call for 30 mg or 60 mg (episodic) or 60 mg (chronic).
• OATP inhibitors: 10 mg or 30 mg once daily for episodic migraine; 30 mg once daily for chronic migraine.
• Severe kidney impairment or end-stage kidney disease: 10 mg once daily for episodic migraine (and, if you are on intermittent dialysis, the dose is preferably taken after dialysis); for chronic migraine, Qulipta is not recommended.
• Severe liver impairment (Child-Pugh C): the label says to avoid Qulipta because of the potential for liver injury. There is no reduced dose for severe liver impairment. No adjustment is needed for mild or moderate liver impairment.

Give your pharmacist a full list of everything you take, including over-the-counter medicines and herbal products; the label specifically tells patients to report grapefruit juice as well, and it is worth asking your pharmacist about grapefruit and St. John's wort, which affect the CYP3A4 pathway atogepant depends on. This page is educational information, not medical advice; your prescriber and pharmacist should make the final call on dose and safety for you.